To determine the impact of the NYS Hepatitis C Testing Law, the NYSDOH drew from multiple data sources that assessed testing levels in New York before and after the law went into effect.
Tag Archive for: Hepatitis C
A network building capacity to prevent, manage and treat hepatitis B and C in NYC
NYS DOH Drug Utilization Review Board Meeting | 4-27-16
Advocacy, News, Hepatitis C, HepCX News, NYS PolicyVOCAL-NY and community leaders will attend the meeting to advocate for unrestricted access to Hepatitis C drug coverage.
The NYS Hep C Coalition has released a 2016 State Budget and Legislative platform.
FDA Approves Daklinza/Sovaldi to Treat Hep C Genotype 1
News, Hepatitis C, HepCX News, PharmaceuticalFDA Expands Daklinza/Sovaldi Approval to Include Treatment of Hep C Genotype 1
Improving Hep C Care for People Who Use Drugs
Training, Harm Reduction, Hepatitis C, Substance AbuseSpecial guests Jason Grebely, Alain Litwin, and Sheila Reynoso presented on best practices to improve Hep C care among people who inject drugs.
2014 NYC Health Dept Hep B & C Annual Report
News, Publications, Reports, Hepatitis B, Hepatitis C, HepCX NewsThe Health Department today released a new report detailing the city’s hepatitis B and C surveillance, research, and programmatic activities in 2014.
The U.S. Food and Drug Administration has approved Zepatier with or without ribavirin for the treatment of chronic Hepatitis C genotypes 1 and 4 infections in adult patients.
Video | Jade: Song of Hope (Hep Free Hawaii & Alex Bocchieri)
Patient Education Materials, Hepatitis C, Patient Stories, VideoJade: Song of Hope is a short documentary film produced by Hep Free Hawai'i and local filmmaker, Alex Bocchieri, to raise awareness about hepatitis C.
NVHR is offering program booster mini grants for one year to member organizations working on hep C education, screening and linkage to care activities. 3 - 6 awards will be given ranging from $5,000 to $10,000 each.
VOCAL-NY is launching this petition campaign to make sure that people know that we need to create a drug pricing system that can never been exploited again.








